$ 395.20 <%= Resources.Global.txtUp %>
Updated 15:04:02
Change % 0.19% Stock price increasing
Change 0.74 Stock price increasing
Volume 24,412
High $ 397.97
Low $ 393.10
Open $ 396.88
Prev close $ 394.46
# of shares 44.28M
Market cap 17,499M USD

Abiomed Inc
Market is open (until 21:00) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  395.20 2.8% Stock price increasing 34.8% Stock price increasing 47.2% Stock price increasing 97.9% Stock price increasing 190.8% Stock price increasing
Powered by TradingView

News about Abiomed Inc

  • English
  • Regulatory news

Company profile

Abiomed provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
25 May 2018 15:19:20
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180525.2 - EUROWEB3 - 2018-05-25 16:19:20 - 2018-05-25 15:19:20 - 1000 - Website: OKAY